NEW DELHI: Dr Dangs Lab has successfully conducted screening, safety and several immunogenicity tests for all the three phases of trial for Biological E’s Corbevax - the first indigenously developed protein-subunit vaccine against COVID-19 and the third vaccine ( after Covaxin and ZyCoV-D) to be made-in-India. Corbevax utilizes the receptor-binding domain from the spike protein as the vaccine antigen.
The timely and high quality reporting of the lab tests for the Corbevax trials - conducted at Dr DANGS LABS in New Delhi - was the result of relentless hard work by the team carried out with clockwork precision under the close watch of experts , featuring deeply orchestrated accurate lab assays, project management, tech transfers and efficient bio-repository management. Rigorous quality benchmarks, such as GCLP guidelines as mandated by regulatory authorities, were adhered to.
“We at Dr. DANGS LABS are humbled and elated to be part of this important milestone. The testing for the Corbevax trial called for close coordination with participating investigative sites, principal investigators as well as efficient handling of pan-India logistics - and the team pulled it off with characteristic efficiency. Proud to have been chosen as the central lab of choice to provide end to end services ", said Dr Arjun Dang, CEO of Dr DANGS LAB.
The development has come in the wake of the Drug Controller General of India (DCGI) approving two new Covid-19 vaccines and one anti-viral drug for emergency use on Tuesday.
Dr DANGS LAB is an NCR based premium lab chain recognized for its ethos of personalised and high quality diagnostic services. It also partners with various institutes and companies for academic research and clinical trials.
*This Press Release is published by VOH team.*
Mindray Innovation Empowers Asian Games Host City Hangzhou and Beyond
Apollo Telehealth: Revolutionizing Healthcare Access Through Innovation
Dr Arvind Sharma appointed as New Executive Committee (EC) member Indian Academy
SRV Hospitals Expands its Footprint with the Launch of its Fifth Hospital in Nas
India's leading Gastroenterologist Dr Amit Maydeo joins Sir HN Reliance Foundati
Sir H. N. Reliance Foundation Hospital Takes Bold Strides to Combat Sepsis; laun
IHH Healthcare increases majority stake in India’s Gleneagles Global Hospitals
CK Birla Hospital Signs MOU with Intuitive India for launching Fourth Gen da Vin
Amrita Hospital, Faridabad, Celebrates First Anniversary of its Founding
Compassion knows no borders: At MSF's Health and Humanity Summit, a new communit
Rare Diseases Policy Summit: A DAY OF RARE INSIGHTS
ZEISS SMILE: Pioneering Vision Correction Technology Experiencing Rapid Adoption
$500K PRE-SERIES A FUNDING FOR MONITRA HEALTHCARE
Revolutionary Breakthrough in Cardiac Healthcare: AI-Powered Screening for Left
Tata 1mg Labs Commits Free Anemia Screenings for 10,000 Women and ChildrenView All